ReviewCurrent allergy and asthma reports2025
Clinical Impact and Management of Antibiotic Allergy in Pregnancy.
Review in Current allergy and asthma reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of this reviewWe review recent literature on impact of antibiotic allergy during pregnancy, and evidence for management in those self-reporting beta-lactam allergy. RECENT
findingsPregnant patients report a high-rate of antibiotic allergy, similar to the general public. Historically, antibiotic allergy evaluation has been reserved for non-pregnant patients, however, growing evidence supports safety and clinical utility for allergy evaluation during pregnancy. Recent studies have supported safety of outpatient skin testing with drug challenge in those with beta-lactam allergy, with most recent findings supportive of direct drug challenge in patients with low-risk allergy phenotypes. Evaluation of allergy label during pregnancy improves first-line antibiotic use of beta-lactam antibiotics. Allergy evaluation during pregnancy is a unique opportunity for allergists to impact clinical outcomes for both maternal and neonatal outcomes. Future studies should focus on standardization of evaluation protocols, improving access to allergy evaluation, and expand knowledge on neonatal clinical outcomes.
Indexed as
Identifiers
41261297What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.